Infantile hemangioma: factors causing recurrence after propranolol treatment.

about

Infantile hemangioma: factors causing recurrence after propranolol treatment.

Item

http://www.wikidata.org/entity/Q50092811

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@en

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@nl

type

Item

label

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@en

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@nl

prefLabel

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@en

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@nl

P1476

Infantile hemangioma: factors causing recurrence after propranolol treatment.

@en

P2093

Dongze Lv

http://www.w3.org/2001/XMLSchema#string

Gang Ma

http://www.w3.org/2001/XMLSchema#string

Hanru Ying

http://www.w3.org/2001/XMLSchema#string

Hui Chen

http://www.w3.org/2001/XMLSchema#string

Lei Chang

http://www.w3.org/2001/XMLSchema#string

Xiaoxi Lin

http://www.w3.org/2001/XMLSchema#string

Yajing Qiu

http://www.w3.org/2001/XMLSchema#string

Yifei Gu

http://www.w3.org/2001/XMLSchema#string

Yunbo Jin

http://www.w3.org/2001/XMLSchema#string

Zhang Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy

Signaling pathways in the development of infantile hemangioma

MicroRNAs: genomics, biogenesis, mechanism, and function

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma

Management of vascular tumors.

Vasculogenesis in infantile hemangioma.

Propranolol targets the contractility of infantile haemangioma-derived pericytes.

Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

P2888

pr.2017.220

P31

scholarly article

P356

10.1038/PR.2017.220

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29019471

http://www.w3.org/2001/XMLSchema#string